Literature DB >> 33764403

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

Michael J Rybak1,2, Jennifer Le3, Thomas P Lodise4, Donald P Levine2,5, John S Bradley6,7, Catherine Liu8, Bruce A Mueller9, Manjunath P Pai9, Annie-Wong Beringer10, Keith A Rodvold11, Holly D Maples12.   

Abstract

Entities:  

Keywords:  vancomycin AKI; vancomycin AUC; vancomycin guidelines; vancomycin monitoring

Year:  2021        PMID： 33764403     DOI： 10.1093/ajhp/zxab123

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  A GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice.

Authors:  Changmeng Cui; Li Zhu; Qian Wang; Ruijuan Liu; Dadi Xie; Yujin Guo; Dingyi Yu; Changshui Wang; Dan Chen; Pei Jiang
Journal:  Heliyon       Date:  2022-07-06

2.  Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant Staphylococcus aureus Endovascular Infections?

Authors:  Warren Rose; Cecilia Volk; Thomas J Dilworth; George Sakoulas
Journal:  Open Forum Infect Dis       Date:  2022-04-09       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.